Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Tuberculosis

Free Subscription 29.03.2021 1 Am J Respir Crit Care Med 1 Antimicrob Agents Chemother 1 Eur Respir J 2 Int J Tuberc Lung Dis 2 Lancet 5 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Respir Crit Care Med

1. BEHR MA, Kaufmann E, Duffin J, Edelstein PH, et al
   Latent Tuberculosis: Two Centuries of Confusion.
   Am J Respir Crit Care Med. 2021 Mar 24. doi: 10.1164/rccm.202011-4239.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

2. FARAJ A, Svensson RJ, Diacon AH, Simonsson USH, et al
   Drug Effect of Clofazimine on Persisters Explains an Unexpected Increase in Bacterial Load in Patients.
   Antimicrob Agents Chemother. 2020;64.
   PubMed         Abstract available
   
   

   
   Eur Respir J

3. BOHLBRO AS, Hvingelby VS, Rudolf F, Wejse C, et al
   Active case-finding of tuberculosis in general populations and at-risk groups: a systematic review and meta-analysis.
   Eur Respir J. 2021 Mar 25. pii: 13993003.00090-2021.
   PubMed         Abstract available
   
   

   
   Int J Tuberc Lung Dis

4. MALABAD JCM, Ang CF, Palabrica FAR, Cajucom MAM, et al
   Molecular epidemiology of Mycobacterium tuberculosis in adult Filipino TB-HIV co-infected patients.
   Int J Tuberc Lung Dis. 2021;25:285-291.
   PubMed         Abstract available
   
   
5. CHIANG CY
   Green Light Committee and WHO recommendations.
   Int J Tuberc Lung Dis. 2020;24:873-874.
   PubMed        
   
   

   
   Lancet

6. LANE R
   Nicole Salazar-Austin: emerging tuberculosis-HIV research leader.
   Lancet. 2021 Mar 18. pii: S0140-6736(21)00587.
   PubMed        
   
   
7. NKEREUWEM E, Kampmann B, Togun T
   The need to prioritise childhood tuberculosis case detection.
   Lancet. 2021 Mar 22. pii: S0140-6736(21)00672.
   PubMed        
   
   

   
   PLoS One

8. HUDDART S, Singh M, Jha N, Benedetti A, et al
   Case fatality and recurrent tuberculosis among patients managed in the private sector: A cohort study in Patna, India.
   PLoS One. 2021;16:e0249225.
   PubMed         Abstract available
   
   
9. HAN WM, Mahikul W, Pouplin T, Lawpoolsri S, et al
   Assessing the impacts of short-course multidrug-resistant tuberculosis treatment in the Southeast Asia Region using a mathematical modeling approach.
   PLoS One. 2021;16:e0248846.
   PubMed         Abstract available
   
   
10. HERMAN B, Sirichokchatchawan W, Pongpanich S, Nantasenamat C, et al
    Development and performance of CUHAS-ROBUST application for pulmonary rifampicin-resistance tuberculosis screening in Indonesia.
    PLoS One. 2021;16:e0249243.
    PubMed         Abstract available
    
    
11. HEFFERNAN C, Paulsen C, Asadi L, Egedahl ML, et al
    Individual and public health consequences associated with a missed diagnosis of pulmonary tuberculosis in the emergency department: A retrospective cohort study.
    PLoS One. 2021;16:e0248493.
    PubMed         Abstract available
    
    
12. GOOVAERTS O, Massinga-Loembe M, Ondoa P, Ceulemans A, et al
    Lack of elevated pre-ART elastase-ANCA levels in patients developing TB-IRIS.
    PLoS One. 2020;15:e0244800.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: